Whilst it would’ve been nice to see our SP a bit higher before a CR, I think it’s a well timed strategic move to ‘get us out of the woods’ with regards to geopolitical and industry sentiment. We should now be funded to mid-2021 by which time we have a PFS and a (hopefully) bullish lithium market.
Their focus now needs to be on our scoping study and PFS. Galan needs to prove to the market that we’re more than just small patch on the fringe of the salar with a few good drill hits. They need to prove that this project can be feasibly turned into a producing mine.
If they can put out a credible scoping study that proves this I think we’re in for a very good rerate.
- Forums
- ASX - By Stock
- Ann: Trading Halt
Whilst it would’ve been nice to see our SP a bit higher before a...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GLN (ASX) to my watchlist
|
|||||
Last
16.0¢ |
Change
-0.035(18.0%) |
Mkt cap ! $75.83M |
Open | High | Low | Value | Volume |
18.5¢ | 18.5¢ | 15.5¢ | $1.405M | 8.435M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 54982 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 1006000 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 54982 | 0.160 |
27 | 1673384 | 0.155 |
29 | 1139032 | 0.150 |
6 | 1401000 | 0.145 |
10 | 540428 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 1006000 | 5 |
0.170 | 562475 | 7 |
0.175 | 221000 | 4 |
0.180 | 115000 | 4 |
0.185 | 130000 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
GLN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online